Study of Vitamin D and Effect on Heart Disease and Insulin Resistance

Completed · Phase 2 · Has a placebo group

Conditions studied: Human Immunodeficiency Virus (HIV), Vitamin D Deficiency, HIV Infections

In brief

The purpose of this study is to evaluate how Vitamin D affects endothelial function, inflammation, lipids, insulin resistance, vitamin D levels, and parathyroid hormone (PTH).

Key facts

Study ID

NCT01093417

Run by

University Hospitals Cleveland Medical Center

People needed

45

Starts

2010-01-01

Expected to finish

2010-10-01

Last updated by the study team

2016-07-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV infected
• HIV-RNA < 400 copies/ml at study entry and for 12 wks. prior
• 25-hydroxyvitamin D level <20
• On a stable anti-retroviral (ARV) regimen for at least 12 weeks prior to study entry

You may not qualify if…

• Pregnancy or Breast Feeding
• Diabetes
• Creatinine Clearance <50
• Any active infectious or inflammatory condition
• aspartate aminotransferase (AST) or alanine aminotransferase (ALT) >2.5 within 6 months prior to study entry

Where it is running

• University Hospitals of Cleveland Case Medical Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.